CamStent Ltd is an emerging medical materials company based in Cambridge, UK. We are focused on building revenues through the development and licensing of proprietary polymer coatings that resist attachment of biofilms..
CamStent’s first commercial product is a compound that prevents catheter-acquired urinary tract infections. Derivative formulations will target other medical and dental applications, as well as consumer and marine products.
CamStent was founded in 2006 when a clinician looking for solution for stent thrombosis met a surface chemist with an interest in non-stick coatings at a Cambridge university lecture. Their collaboration became a company developing biofilm-resistant coatings for medical, consumer, and marine applications.
Camstent follows medical device industry best practices, guided by ISO and national regulatory guidelines and standards.
The first product is currently in late-research phase, funded by an EEDA research grant and early stage investors. Validation tasks will take one year to complete, and include tailoring the coating to bond with catheter substrates and demonstrating effective resistance against relevant microorganisms.
With a successful demonstration of the component feasibiility, the product will rapidly be brought to commercial readiness in the subsequent 24 months during which optimization, CE Mark approval and a short clinical study will take place.